In tests using animals, drug successfully seeks and disarms toxic clumps of proteins responsible for Alzheimer’s and Parkinson’s
An international team of more than 18 research groups has demonstrated that the compounds they developed can safely prevent harmful protein aggregation in preliminary tests using animals. The findings raise hope that a new class of drugs may be on the horizon for the more than 30 diseases and conditions that involve protein aggregation, including diabetes, cancer, spinal cord injury, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Proteins are necessary for almost every cellular process. However, when cell machinery doesn’t clear out old proteins, they can clump, or aggregate, into toxic plaques that lead to disease.
“Diseases caused by protein aggregation affect millions of people around the world,” said Gal Bitan, Ph.D., associate professor of neurology at the David Geffen School of Medicine at the University of California – Los Angeles, who will present the team’s latest work at the American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting during Experimental Biology 2015. “We hope that the new compounds will provide therapy for diseases caused by protein aggregation, many of which have no treatment at all.”
The researchers call the compounds that they developed molecular tweezers because of the way they wrap around the lysine amino acid chains that make up most proteins. The compounds are unique in their ability to attack only aggregated proteins, leaving healthy proteins alone.
To develop a new drug, researchers typically screen large libraries of compounds to find ones that affect a protein involved in a disease. Bitan’s team used a fundamentally different approach to develop the molecular tweezers.
“We looked at the molecular and atomic interactions of proteins to understand what leads to their abnormal clumping,” Bitan said. “Then, we developed a tailored solution. So unlike many other drugs, we understand how and why our drug works.”
The team is in the process of testing multiple versions of the tweezers, each with a slightly different molecular makeup. For CLR01, one of the most promising versions, the researchers have demonstrated therapeutic benefits in two rodent models of Alzheimer’s disease, two fish and one mouse model of Parkinson’s disease, a fish model of spinal cord injury and a mouse model of familial amyloidotic polyneuropathy, a rare disease in which protein aggregation affects the nervous system, heart and kidneys.
“Our data suggest that CLR01, or a derivative thereof, may become a drug for a number of diseases that involve protein aggregation,” Bitan said. “We also found a high safety window for CLR01.”
In one of the safety tests, mice receiving a daily CLR01 dose 250 times higher than the therapeutic dose for one month showed no behavioral or physiological signs of distress or damage. In fact, blood cholesterol in the mice dropped by 40 percent, a possible positive side effect of CLR01.
The Latest on: Molecular tweezers
via Google News
The Latest on: Molecular tweezers
- New Productson March 19, 2020 at 11:53 am
Because the filter is ideally suited for low-dose imaging applications, researchers can maximize their cryo-EM and cryo-electron tomography (cryo-ET) capabilities to gain further insight into system ...
- Supercomputers drive ion transport researchon March 4, 2020 at 1:17 am
Advanced path sampling techniques and molecular dynamics (MD) simulations captured the kinetics of solute transport through nanoporous membranes, according to a study published online in the Cell ...
- Observing Cell Surface Signaling Domains Using Electron Microscopyon March 3, 2020 at 4:00 pm
1 The Physiological Laboratory, University of Liverpool, UK. 2 Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia. 3 Centre for Microscopy and Microanalysis, University ...
- Cardiac cell–integrated microneedle patch for treating myocardial infarctionon March 3, 2020 at 4:00 pm
1 Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. 2 Department of Molecular Biomedical Sciences and Comparative Medicine Institute, ...
- Toward broadband, dynamic structuring of a complex plasmonic fieldon March 3, 2020 at 4:00 pm
2 Department of Chemistry and Physics, La Trobe Institute for Molecular Science, La Trobe University ... 7), superresolution imaging (8, 9), plasmonic tweezers (10, 11), in-plane communications (12), ...
- Max Planck Institute of Molecular Cell Biology and Geneticson March 1, 2020 at 4:00 pm
How do cells form tissues? How do tissues form organisms? Cell and developmental biologists at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden devote their research to ...
- Spectrochimica acta. Part A, Molecular and biomolecular spectroscopyon February 19, 2020 at 4:00 pm
Rapid quantitation of atorvastatin in process pharmaceutical powder sample using Raman spectroscopy and evaluation of parameters related to accuracy of analysis. Fast detection of fenthion on ...
- Molecular 'first responder' that triggers plaques uncoveredon February 4, 2020 at 4:00 pm
Oxford University scientist have discovered the molecular 'first responder' which ... "We used very tiny magnetic 'tweezers' to pull on the Plexin D1 protein, and we found that it responded ...
- Ice crystals in nanotubes, plus optical tweezers for nanosurgery, organic electronics and a molecular 'rack-and-pinion' deviceon February 25, 2019 at 5:15 am
All prices are NET prices. VAT will be added later in the checkout.
- Projects and Mentorson November 24, 2018 at 2:30 pm
Equipment/techniques participants will learn and use: fluorescence microscope; optical tweezers; general biochemical and biophysical ... The other participant, primarily doing molecular parasitology ...
via Bing News